Study of MB07811 in Subjects With Hypercholesterolemia

PHASE2WithdrawnINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Hypercholesterolemia
Interventions
DRUG

MB07811

Oral

DRUG

Placebo

Oral

Trial Locations (11)

23294

National Clinical Research, Richmond

23502

National Clinical Research - Norfolk, Norfolk

29445

Coastal Carolina Research Center, Inc., Goose Creek

32216

Jacksonville Center for Clinical Research, Jacksonville

33024

University Clinical Research, Pembroke Pines

42431

Commonwealth Biomedical Research, Madisonville

46260

Midwest Institute for Clinical Research, Indianapolis

48098

Troy Internal Medicine, Troy

60654

Radiant Research, Chicago

75234

Research Across America, Dallas

92128

Scripps Clinic, Clinical Research, San Diego

Sponsors
All Listed Sponsors
lead

Ligand Pharmaceuticals

INDUSTRY